Drugs / BMS-954561
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01314222 | Mar 2011 → Mar 2012 | diabetic polyneuropathy | Bristol-Myers Squibb | Completed | No outcome recorded |
| Phase 2 | NCT01305538 | Mar 2011 → Feb 2012 | postherpetic neuralgia | Bristol-Myers Squibb | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BMS-954561 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01314222 ↗ |